CCAAT/enhancer-binding protein alpha (CEBPA) gene haploinsufficiency does not alter hematopoiesis or induce leukemia in Lck-CALM/AF10 transgenic mice
Carregando...
Citações na Scopus
2
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
Associação Brasileira de Divulgação Científica
Autores
LANGE, A.P.
ALMEIDA, L.Y.
ARAÚJO SILVA, C.L.
SCHEUCHER, P.S.
CHAHUD, F.
KRAUSE, A.
BOHLANDER, S.K.
Citação
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, v.52, n.6, p.e8424, 2019
Resumo
Although rare, CALM/AF10 is a chromosomal rearrangement found in immature T-cell acute lymphoblastic leukemia (T-ALL), acute myeloid leukemia, and mixed phenotype acute leukemia of T/myeloid lineages with poor prognosis. Moreover, this translocation is detected in 50% of T-ALL patients with gamma/delta T cell receptor rearrangement, frequently associated with low expression of transcription factor CCAAT/enhancer-binding protein alpha (CEBPA). However, the relevance of CEBPA low expression for CALM/AF10 leukemogenesis has not yet been evaluated. We generated double mutant mice, which express the Lck-CALM/AF10 fusion gene and are haploinsufficient for the Cebpa gene. To characterize the hematopoiesis, we quantified hematopoietic stem cells, myeloid progenitor cells, megakaryocyte-erythrocyte progenitor cells, common myeloid progenitor cells, and granulocyte-macrophage progenitor cells. No significant difference was detected in any of the progenitor subsets. Finally, we tested if Cebpa haploinsufficiency would lead to the expansion of Mac-1+/B220+/c-Kit+ cells proposed as the CALM/AF10 leukemic progenitor. Less than 1% of bone marrow cells expressed Mac-1, B220, and c-Kit with no significant difference between groups. Our results showed that the reduction of Cebpa gene expression in Lck-CALM/AF10 mice did not affect their hematopoiesis or induce leukemia. Our data corroborated previous studies suggesting that the CALM/AF10 leukemia-initiating cells are early progenitors with lymphoid/myeloid differentiating potential.
Palavras-chave
Leukemia, CEBPA, CALM/AF10, Transgenic mice
Referências
- Bell JJ, 2008, NATURE, V452, P764, DOI 10.1038/nature06840
- Ben Abdelali R, 2013, HAEMATOLOGICA, V98, P1711, DOI 10.3324/haematol.2013.086082
- Bienz M, 2005, CLIN CANCER RES, V11, P1416, DOI 10.1158/1078-0432.CCR-04-1552
- GREGOIRE MJ, 1993, LEUKEMIA, V7, P10
- Guibal FC, 2009, BLOOD, V114, P5415, DOI 10.1182/blood-2008-10-182071
- Ohlsson E, 2016, LEUKEMIA, V30, P767, DOI 10.1038/leu.2015.324